139 related articles for article (PubMed ID: 6183898)
1. 65Zinc absorption in untreated and D-penicillamine-treated patients with generalized scleroderma: determination by whole-body counting technique.
Høyer H; Hvid-Jacobsen K; Weismann K
Acta Derm Venereol; 1982; 62(5):438-40. PubMed ID: 6183898
[TBL] [Abstract][Full Text] [Related]
2. Effects of tetracycline on the absorption of 65zinc in rats.
Weismann K; Knudsen L; Høyer H
Arch Dermatol Res; 1978 Nov; 263(2):135-8. PubMed ID: 104665
[TBL] [Abstract][Full Text] [Related]
3. Technique for determination of human zinc absorption from measurement of radioactivity in a fecal sample or the body.
Payton KB; Flanagan PR; Stinson EA; Chodirker DP; Chamberlain MJ; Valberg LS
Gastroenterology; 1982 Dec; 83(6):1264-70. PubMed ID: 6813186
[TBL] [Abstract][Full Text] [Related]
4. Treatment of generalized scleroderma with inhibitors of connective tissue formation.
Asboe-Hansen G
Acta Derm Venereol; 1975; 55(6):461-5. PubMed ID: 55038
[TBL] [Abstract][Full Text] [Related]
5. Effect of oral zinc sulphate and penicillamine on zinc metabolism in patients with rheumatoid arthritis.
Kennedy AC; Bessent RG; Reynolds PM
J Rheumatol; 1980; 7(5):639-44. PubMed ID: 7441655
[TBL] [Abstract][Full Text] [Related]
6. Zinc and zinc-dependent enzymes in penicillamine-treated patients with generalized scleroderma.
Jepsen LV; Eggert J
Acta Derm Venereol; 1984; 64(5):424-7. PubMed ID: 6208723
[TBL] [Abstract][Full Text] [Related]
7. [Treatment of systemic scleroderma with D-penicillamine. Results in 14 patients treated for more than a year].
Kahn MF; Bourgeois P; Brion N; Elleuch M
Rev Rhum Mal Osteoartic; 1986 Jan; 53(1):35-8. PubMed ID: 3704510
[TBL] [Abstract][Full Text] [Related]
8. Effects of penicillamine and hydroxyquinoline on absorption of orally ingested 65zinc in the rat.
Weismann K; Knudsen L
J Invest Dermatol; 1978 Oct; 71(4):242-4. PubMed ID: 151717
[TBL] [Abstract][Full Text] [Related]
9. D-penicillamine treatment of progressive systemic sclerosis (scleroderma): a comparison of clinical and in vitro effects.
Shapiro LS; Prince RK; Buckingham RB; Rodnan GP
J Rheumatol; 1983 Apr; 10(2):316-8. PubMed ID: 6864687
[TBL] [Abstract][Full Text] [Related]
10. Effect of zinc on biological half-lives of 65Zn in whole body and liver and on distribution of 65Zn in different organs of rats following nickel toxicity.
Sidhu P; Garg ML; Dhawan DK
Biol Trace Elem Res; 2004; 102(1-3):173-88. PubMed ID: 15621937
[TBL] [Abstract][Full Text] [Related]
11. 65Zinc absorption in patients suffering from acrodermatitis enteropathica and in normal adults assessed by whole-body counting technique.
Weismann K; Hoe S; Knudsen L; Sørensen SS
Br J Dermatol; 1979 Nov; 101(5):573-9. PubMed ID: 117822
[TBL] [Abstract][Full Text] [Related]
12. Predictors and outcomes of scleroderma renal crisis: the high-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis trial.
DeMarco PJ; Weisman MH; Seibold JR; Furst DE; Wong WK; Hurwitz EL; Mayes M; White B; Wigley F; Barr W; Moreland L; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner SR; Andrews B; Abeles M; Clements PJ
Arthritis Rheum; 2002 Nov; 46(11):2983-9. PubMed ID: 12428241
[TBL] [Abstract][Full Text] [Related]
13. Does long-term treatment with D-penicillamine alter calcium and phosphorus metabolism in patients with systemic sclerosis?
Hagdrup H; Serup J; Tvedegaard E
Acta Derm Venereol; 1983; 63(5):447-9. PubMed ID: 6197850
[TBL] [Abstract][Full Text] [Related]
14. [Effect of penicillin and D-penicillamine on beta-galactosidase activity in patients with progressive scleroderma].
Schulze E; Herrmann K; Haustein UF; Krusche U; Rothenburger I
Dermatol Monatsschr; 1988; 174(11):661-6. PubMed ID: 3145222
[No Abstract] [Full Text] [Related]
15. [Obliterating bronchiolitis induced by D-penicillamine in the female patient with systemic scleroderma].
Alekperov RT; Avdeev SN; Kotovskaia MA
Ter Arkh; 2004; 76(3):74-6. PubMed ID: 15108466
[No Abstract] [Full Text] [Related]
16. Treatment of generalized scleroderma: updated results.
Asboe-Hansen G
Acta Derm Venereol; 1979; 59(5):465-7. PubMed ID: 93375
[TBL] [Abstract][Full Text] [Related]
17. Penicillamine for scleroderma.
Fulghum DD; Katz R
Arch Dermatol; 1968 Jul; 98(1):51-2. PubMed ID: 5241672
[No Abstract] [Full Text] [Related]
18. High-dose versus low-dose D-penicillamine in early diffuse systemic sclerosis: analysis of a two-year, double-blind, randomized, controlled clinical trial.
Clements PJ; Furst DE; Wong WK; Mayes M; White B; Wigley F; Weisman MH; Barr W; Moreland LW; Medsger TA; Steen V; Martin RW; Collier D; Weinstein A; Lally E; Varga J; Weiner S; Andrews B; Abeles M; Seibold JR
Arthritis Rheum; 1999 Jun; 42(6):1194-203. PubMed ID: 10366112
[TBL] [Abstract][Full Text] [Related]
19. Progressive systemic sclerosis and penicillamine.
Rodnan GP
J Rheumatol Suppl; 1981; 7():116-20. PubMed ID: 6939873
[TBL] [Abstract][Full Text] [Related]
20. [Microcirculatory disorders in systemic scleroderma treated with d-penicillamine].
Nasonova VA; Alekberova ZS; Mach ES; Balabanova RM
Klin Med (Mosk); 1981 Nov; 59(11):57-61. PubMed ID: 7321499
[No Abstract] [Full Text] [Related]
[Next] [New Search]
